Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30

$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Pure Bioscience's EV/EBITDA was 34.5× on May 28, 2021.

Period	Period end	Value	Change (pts)
2021	May 28, 2021	34.5×	−22.1
2020	Dec 31, 2020	56.5×	–

Parsed from the XBRL in Pure Bioscience's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-8 reverse split on Aug 15, 2012
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing